26 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34790076 | Antithrombin III Supplementation in a Premature Infant: Is There a Target Antithrombin Level? | 2021 | 1 |
2 | 31986476 | Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients. | 2020 Mar | 1 |
3 | 30262570 | THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. | 2019 Apr | 1 |
4 | 30181723 | Effect of Exogenous Antithrombin Administration on Anti-Xa Levels in Infants Treated With Enoxaparin. | 2018 Jul-Aug | 5 |
5 | 28282887 | New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin. | 2017 Mar 8 | 1 |
6 | 29031112 | Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis. | 2017 Nov 15 | 1 |
7 | 26758598 | Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR. | 2016 Feb | 1 |
8 | 26280926 | Analytical and statistical comparability of generic enoxaparins from the US market with the originator product. | 2015 Nov 10 | 1 |
9 | 24375987 | Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis. | 2014 Jun | 2 |
10 | 24616065 | Affinity capillary electrophoresis for the determination of binding affinities for low molecular weight heparins and antithrombin-III. | 2014 May | 1 |
11 | 17489664 | Enoxaparin in acute coronary syndromes. | 2007 May | 1 |
12 | 17600038 | Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. | 2007 Sep | 1 |
13 | 17621651 | Macroscopic thrombus formation on angioplasty equipment following antithrombin therapy with enoxaparin. | 2007 Nov 15 | 4 |
14 | 16675258 | Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively. | 2006 Jun | 1 |
15 | 16685318 | Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment. | 2006 May 1 | 1 |
16 | 15860994 | Low-molecular-weight heparin in patients with acute ST-segment elevation myocardial infarction. | 2005 Spring | 1 |
17 | 15957976 | Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes. | 2005 Jun | 1 |
18 | 16124953 | A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes. | 2005 Apr | 1 |
19 | 15210403 | Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. | 2004 Apr 30 | 1 |
20 | 15238596 | Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. | 2004 Jul 7 | 1 |
21 | 11812067 | Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. | 2002 Feb | 1 |
22 | 11287128 | Antithrombin binding of low molecular weight heparins and inhibition of factor Xa. | 2001 Apr 3 | 1 |
23 | 11755953 | The lack of effect of a prophylactic dose of enoxaparin on thrombin generation in patients subjected to nephrectomy because of kidney cancer. | 2001 Dec 15 | 1 |
24 | 14728009 | Enoxaparin: in the prevention of venous thromboembolism in medical patients. | 2001 | 2 |
25 | 8165617 | Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma. | 1993 Dec 20 | 1 |
26 | 1848441 | Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers. | 1991 Feb | 2 |